Biomarkers Market – An Overview
Biomarkers or biological markers are often referred to indicators that give a fair analysis of the biological conditions of living organisms. It can be used to indicate the presence of certain conditions or symptoms that might escape the regular diagnosis.
The Biomarkers are used to examine the physiological processes, pathogenic processes, or even a response to a particular therapeutic drug. Used mostly in scientific fields, these biological markers have found widespread usage in medicine as well. Be it a radioactive isotope to identify the perfusion of the cardio-vascular muscles or simply detecting antigens in the blood; these markers play an important role in every aspect.
Body temperature, the pigmentation of the mucous et al. are natural biomarkers. Similar functions are carried out by these artificial biomarkers, which play a key role in detecting the issues which otherwise would have escaped a pathological test or a specialist’s diagnosis. If an individual had been working in an environment that has been exposed to nuclear radiation or any circumstance where the impact is undesirable by the body, biomarkers could help identify those with ease.
Different systems such as cardiovascular systems, neurological systems, respiratory systems, excretory systems et al. respond to different biomarkers. These make detection of diseases easier without resorting to any major invasive processes. Biomarkers can be used individually or in combination depending on the process.
Various measurements of the body can be used as natural biomarkers to analyze the BMI, body to hip ratio can be used to assess the risk of developing obesity or even diabetes! Biomarkers are expected to be consistent across all genders and ethnic groups making it universal in terms of usage. Additionally, if it is cost-effective, easy to measure and allows a wider range of modification when it comes to treatment, the better. A lot of research is underway in multiple government and private institutions to make biomarkers affordable and accessible to patients and hospitals.
Increasing number of clinical trials and a boom in the Market has opened up different opportunities for the biomarkers market to grow. Breakthrough in cancer research and cure has added to the increase in demand. With a compound annual growth rate of 13.44%, an industry that had a revenue cap of $24.55 billion in 2015 is expected to grow exponentially and record a margin of $46.112 billion by 2020. An increased traction in research and development in terms of drug development, inexpensive drug trials, driven initiatives to find a cure for critical diseases are expected to drive the market to new heights during the forecasted period.
Biomarkers can be in different forms. It could be a simple software or a consumable product depending on the condition one is trying to detect. If recent developments are to be considered, there are pills that can be consumed as regular ones to treat cancer cells. Moreover, one might wonder how! These lithium pills have marking qualities that target the malignant cancer cells. Once consumed, it disintegrates in the body and attaches itself to these harmful cells.
The process can be observed thoroughly through probes that are attached with 3D cameras. These cameras assist the surgeons to focus on these impacted cells and treat it with lasers that further breaks down the entire malignant composition making the area cancer-free. Even if the development is in its nascent stages, it is expected to gain a commercial platform no sooner than ever. Therefore, it hardly comes as a surprise that the consumable biomarkers have the largest market share in terms of product circulation. Geographically, North America is the largest shareholder of the biomarkers globally. However, the Asia Pacific countries are expected to catch up to the numbers soon.
Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Biomarkers Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.
The post Is the research on cancer driving the biomarkers market? appeared first on Research Reports Web.